Luis Juarez-Villegas
Overview
Explore the profile of Luis Juarez-Villegas including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
59
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Velasco-Hidalgo L, Gonzalez-Garay A, Rivera-Luna R, Zapata-Tarres M, Galvan-Diaz C, Lopez-Facundo A, et al.
Bol Med Hosp Infant Mex
. 2024 Nov;
81(6):328-336.
PMID: 39576698
Background: Langerhans cell histiocytosis (LCH) is a rare neoplastic disease characterized by clonal proliferation of den-dritic cells. It is Mexico's ninth most frequent malignancy in patients under 18 years of...
2.
Moreno-Lorenzana D, Juarez-Velazquez R, Reyes-Leon A, Martinez-Anaya D, Juarez-Villegas L, Zapata Tarres M, et al.
Leuk Lymphoma
. 2024 Jul;
65(12):1853-1863.
PMID: 39034479
Rearrangements and overexpression of are hallmarks of poor outcomes in -like B-ALL, and overexpression is a high-risk marker in T-ALL. However, alterations in pediatric hematologic malignancies other than B-ALL have...
3.
Tejeda-Castellanos X, Sanchez-Medina C, Marquez-Gonzalez H, Alaniz-Arcos J, Ortiz-Cornejo M, Brito-Suarez J, et al.
BMC Pediatr
. 2023 Oct;
23(1):513.
PMID: 37845644
Aim: We evaluated fine motor skills; precision, motor integration, manual dexterity, and upper-limb coordination according to sex and risk stratification in children with Acute Lymphoblastic Leukaemia (ALL). Methods: We evaluated...
4.
Martinez-Anaya D, Moreno-Lorenzana D, Reyes-Leon A, Juarez-Figueroa U, Dean M, Aguilar-Hernandez M, et al.
Int J Mol Sci
. 2022 Sep;
23(17).
PMID: 36076986
Ph-like subtypes with abnormalities are frequent among Hispano-Latino children with pre-B ALL. Therefore, there is solid ground to suggest that this subtype is frequent in Mexican patients. The genomic complexity...
5.
Dorantes-Acosta E, Avila-Montiel D, Dominguez Rojas J, Parra-Niganez P, Velasco-Hidalgo L, Arias S, et al.
Front Pediatr
. 2022 Aug;
10:928612.
PMID: 36016876
The new COVID-19 disease is caused by a novel coronavirus (SARS-CoV-2), that probably originated in Wuhan, China, and has currently infected 505,817,953 people and caused 6,213,876 deaths in the world....
6.
Azamar A, Torre-Gonzalez C, Juarez-Villegas L, Sadowinski-Pine S, Alvarez-Neri H
Bol Med Hosp Infant Mex
. 2021 Sep;
78(5):461-466.
PMID: 34571519
Background: A relatively frequent clinical finding in children is an asymmetric tonsil, which can have multiple etiological possibilities, including a malignant disease. The clinical finding of tonsillar asymmetry is found...
7.
Dorantes-Acosta E, Avila-Montiel D, Klunder-Klunder M, Juarez-Villegas L, Marquez-Gonzalez H
Front Oncol
. 2021 Feb;
10:608282.
PMID: 33552980
Background: The pandemic caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has affected all age groups, including the pediatric population, in 3-5% of all cases. We performed...
8.
Palomo-Colli M, Fuentes-Lugo A, Cobo-Ovando S, Juarez-Villegas L
J Pediatr Hematol Oncol
. 2020 Dec;
43(7):e1047-e1048.
PMID: 33323882
No abstract available.
9.
Saucedo-Campos A, Islas-Perez A, Lopez-Martinez B, Parra-Ortega I, Ramirez-Perez S, Escobar-Sanchez A, et al.
Bol Med Hosp Infant Mex
. 2020 Nov;
77(6):327-330.
PMID: 33186348
Background: Background">Rare subgroups of pediatric patients with acute myeloid leukemia (AML), such as t(16:21) (p11;q22), require international cooperation to establish a proper stratification system to assign clinical risk. Case Report:...
10.
Dorantes-Acosta E, Avila-Montiel D, Klunder-Klunder M, Juarez-Villegas L, Marquez-Gonzalez H
Bol Med Hosp Infant Mex
. 2020 Oct;
77(5):234-241.
PMID: 33064683
Background: Coronavirus disease (COVID)-19 has currently affected 8,015,502 million people worldwide with global mortality around 5%. Information in pediatric cancer patients is still limited, but it is emerging day by...